NDC 68982-153

NUWIQ

Antihemophilic Factor (recombinant)

NUWIQ is a Intravenous Kit in the Plasma Derivative category. It is labeled and distributed by Octapharma Usa Inc. The primary component is .

• Product ID: 68982-153_b820bdc4-4c06-2947-c30d-fc0a44c57507
• NDC: 68982-153
• Product Type: Plasma Derivative
• Proprietary Name: NUWIQ
• Generic Name: Antihemophilic Factor (recombinant)
• Dosage Form: Kit
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-12-12
• Marketing Category: BLA /
• Application Number: BLA125555
• Labeler Name: Octapharma USA Inc
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 68982-153-01

1 KIT in 1 CARTON (68982-153-01) * 2.5 mL in 1 VIAL (68982-154-01) * 2.5 mL in 1 VIAL (68982-901-01)

• Marketing Start Date: 2021-12-12
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "NUWIQ" or generic name "Antihemophilic Factor (recombinant)"

NDC	Brand Name	Generic Name
68982-139	NUWIQ	NUWIQ
68982-143	NUWIQ	NUWIQ
68982-147	NUWIQ	NUWIQ
68982-149	NUWIQ	NUWIQ
68982-141	NUWIQ	NUWIQ
68982-145	NUWIQ	NUWIQ
68982-151	NUWIQ	NUWIQ
0026-3782	Kogenate FS	Antihemophilic Factor (Recombinant)
0026-3783	Kogenate FS	Antihemophilic Factor (Recombinant)
0026-3785	Kogenate FS	Antihemophilic Factor (Recombinant)
0026-3786	Kogenate FS	Antihemophilic Factor (Recombinant)
0026-3787	Kogenate FS	Antihemophilic Factor (Recombinant)
0026-3821	Kovaltry	Antihemophilic Factor (Recombinant)
0026-3822	Kovaltry	Antihemophilic Factor (Recombinant)
0026-3824	Kovaltry	Antihemophilic Factor (Recombinant)